Does low DHEA-S indicate reduced adrenal androgen reserve and broader HPA-axis under-signaling?

Serum dehydroepiandrosterone sulfate (DHEA-S) serves as a stable, integrated biomarker of adrenal function due to its long circulating half-life and minimal diurnal variation. For a 34-year-old male, low age-adjusted DHEA-S levels provide critical insights into both localized adrenal capacity and systemic neuroendocrine signaling.

Adrenal androgen reserve and clinical evidence

• Zona reticularis capacity: DHEA-S is synthesized almost exclusively in the adrenal zona reticularis (ZR). Abnormally low circulating levels indicate a depleted functional adrenal androgen precursor pool.
• Structural atrophy: Chronically low DHEA-S levels signal a lack of trophic stimulation. This is clinically observed in primary adrenal failure or prolonged secondary adrenal insufficiency, where chronic lack of stimulation leads to physical atrophy of the ZR.

HPA-axis under-signaling and mechanistic pathways

• ACTH drive deficiency: Because ZR steroidogenesis depends on adrenocorticotropic hormone (ACTH), low DHEA-S levels point to reduced upstream pituitary drive and central HPA-axis hypoactivity.
• Allostatic shift and exhaustion: Under chronic physiological or psychological stress, the HPA axis adapts by shifting resources. This functional "burnout" pattern selectively favors glucocorticoid synthesis over androgen precursors, lowering the DHEA-S-to-cortisol ratio.
• Blunted stress reactivity: When low DHEA-S occurs alongside low morning cortisol, it correlates with a blunted cortisol awakening response (CAR), confirming a comprehensive state of HPA-axis under-signaling and reduced physiological stress reactivity.

Bottom line

• Low DHEA-S is a validated biological marker indicating a reduced adrenal androgen reserve and systemic HPA-axis under-signaling, driven by either a lack of trophic ACTH support or chronic stress-induced neuroendocrine exhaustion.